Skip to main content
. 2015 Nov 23;10(11):e0140627. doi: 10.1371/journal.pone.0140627

Fig 4. Overview of presumed factors and their interrelation influencing the progression of Fabry cardiomyopathy.

Fig 4

BNP, Brain-natriuretic peptide; EDV, End-diastolic volume; GB3, globotriaosylceramide; LA, Left atrium; LV, Left ventricle.